Marta Colomer-Lluch, Lauren S Gollahon, Ruth Serra-Moreno1. 1. Biological Sciences. Texas Tech University, 8th and Canton Ave. Experimental Sciences Building Room 113, Box 43131. Lubbock, Texas 79409-3131, USA. ruth.serra-moreno@ttu.edu.
Abstract
BACKGROUND: Similar to other animal viruses, HIV-1 relies on the contributions of the cellular machinery to ensure efficient virus propagation. However, human cells have evolved refined mechanisms to block key steps of the virus life-cycle, thereby suppressing viral replication. These cellular proteins are generally known as restriction factors, and they provide an early antiviral defense. So far, five potent restriction factors have been shown to effectively block HIV and/or SIV replication. These are TRIM5 proteins, SAMHD-1, members of the APOBEC3 (A3) family, Mx2 and Tetherin/BST-2. RESULTS: Here, we review the antiviral mechanisms of these and other antiviral factors, their interaction with the innate immune responses, and how their functions might be exploited to clear and prevent HIV infection. CONCLUSION: Since the majority of vaccine approaches against HIV have failed so far, it is imperative to start looking at alternative strategies for vaccine and therapy development. By better understanding how HIV hijacks the cellular machinery for its own benefit in completing its life-cycle, and how the virus adapts to circumvent our intrinsic immunity, we will be better equipped to design compounds that specifically interrupt virus replication and spread.
BACKGROUND: Similar to other animal viruses, HIV-1 relies on the contributions of the cellular machinery to ensure efficient virus propagation. However, human cells have evolved refined mechanisms to block key steps of the virus life-cycle, thereby suppressing viral replication. These cellular proteins are generally known as restriction factors, and they provide an early antiviral defense. So far, five potent restriction factors have been shown to effectively block HIV and/or SIV replication. These are TRIM5 proteins, SAMHD-1, members of the APOBEC3 (A3) family, Mx2 and Tetherin/BST-2. RESULTS: Here, we review the antiviral mechanisms of these and other antiviral factors, their interaction with the innate immune responses, and how their functions might be exploited to clear and prevent HIV infection. CONCLUSION: Since the majority of vaccine approaches against HIV have failed so far, it is imperative to start looking at alternative strategies for vaccine and therapy development. By better understanding how HIV hijacks the cellular machinery for its own benefit in completing its life-cycle, and how the virus adapts to circumvent our intrinsic immunity, we will be better equipped to design compounds that specifically interrupt virus replication and spread.
Authors: Stephanie M Dillon; Kejun Guo; Gregory L Austin; Sara Gianella; Phillip A Engen; Ece A Mutlu; John Losurdo; Garth Swanson; Prachi Chakradeo; Ali Keshavarzian; Alan L Landay; Mario L Santiago; Cara C Wilson Journal: AIDS Date: 2018-07-31 Impact factor: 4.177
Authors: Ousman Jobe; Jiae Kim; Eric Tycksen; Sayali Onkar; Nelson L Michael; Carl R Alving; Mangala Rao Journal: Front Immunol Date: 2017-10-23 Impact factor: 7.561
Authors: Romel D Mackelprang; Michael J Bamshad; Jessica X Chong; Xuanlin Hou; Kati J Buckingham; Kathryn Shively; Guy deBruyn; Nelly R Mugo; James I Mullins; M Juliana McElrath; Jared M Baeten; Connie Celum; Mary J Emond; Jairam R Lingappa Journal: PLoS Pathog Date: 2017-11-06 Impact factor: 6.823